Médecins Sans Frontières calls on the European Union to take concrete actions to boost the regional fight against TB, including tripling European funding for research and development.

The decentralised model is aimed at diagnosing and treating the majority of DR-TB patients in primary health clinics, instead of being required to be hospitalised for up to six months.

Lack of political commitment will jeopardize momentum for stronger TB action across the region.

New and promising DR-TB drugs are grabbing headlines but not reaching patients.

It is essential to conduct studies that can determine whether this mutation is present in neighboring countries such as South Africa or Mozambique: “If we’re facing wide distribution of this strain in Southern Africa or elsewhere, it is imperative that the rapid molecular tests we currently use, as well as those under development, be adapted to detect a wider range of mutations”.

Ahead of the 1st Eastern Partnership Ministerial Conference on Tuberculosis (TB) and Multidrug Resistant Tuberculosis due to be held in Riga, Latvia on March 30-31, 2015 Médecins Sans Frontières (MSF) shares their experience and recommedations on how to address the deadly gaps in fighting TB.

A medical forum in Armenia gathers health authorities and specialists to discuss tuberculosis, one of the main public health issues in the region. New drugs and therapeutic approaches give hope of better treatment outcomes. Joint and renewed efforts are needed to obtain a better access to the most effective drugs and new treatment regimens for the resistant form of the disease.

New Delhi, 21 January, 2014—Ahead of US President Obama’s visit to India, the international medical humanitarian organisation Médecins Sans Frontières/ Doctors Without Borders (MSF) expressed deep concern over the US government’s heightened efforts  to undermine access to affordable medicines from India—often called the ‘pharmacy of the developing world.’ Millions of people across the globe rely on Indian low-cost generics, just as MSF relies on these to carry out its medical work.

A recent resurgence of TB and the spread of drug-resistant forms makes it an urgent concern.

Médecins Sans Frontières responds to the news of the donation: